BIOLASE, Inc. (BIOL)
| Market Cap | 97.25M |
| Revenue (ttm) | 24.44M |
| Net Income (ttm) | -14.28M |
| Shares Out | 81.34M |
| EPS (ttm) | -0.71 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Dividend Yield | n/a |
| Trading Day | January 22 |
| Last Price | $1.04 |
| Previous Close | $1.09 |
| Change ($) | -0.05 |
| Change (%) | -4.59% |
| Day's Open | 1.10 |
| Day's Range | 1.01 - 1.10 |
| Day's Volume | 34,965,996 |
| 52-Week Range | 0.23 - 1.10 |
While most of Wall Street focuses on large- and mega-cap stocks, as they provide a degree of safety and liquidity, many investors are limited in the number of shares they can buy.
Biolase (BIOL) stock is flying high on Tuesday after announcing a massive deal for its dental lasers with Dental Care Alliance. The post BIOL Stock Alert: 14 Things for Potential Investors to ...
This article is going to explain what penny stocks are and discuss four penny stocks under $1 to watch as small-cap stocks continue a hot streak this winter. First thing's first, what are penn...
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data. We at Insider Monkey have plowed through ...
FOOTHILL RANCH, Calif., Nov. 13, 2020 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced it has been invited to participate in the Benchmark Comp...
BIOLASE, Inc. (BIOL) CEO Todd Norbe on Q3 2020 Results - Earnings Call Transcript
FOOTHILL RANCH, Calif., Nov. 5, 2020 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced that it will release third quarter 2020 financial and ope...
FOOTHILL RANCH, Calif., Oct. 27, 2020 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced that it has made available an updated corporate presenta...
FOOTHILL RANCH, Calif., Oct. 14, 2020 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced unaudited preliminary revenue results for the third quar...
FOOTHILL RANCH, Calif., Sept. 11, 2020 /PRNewswire/ -- BIOLASE, Inc.
FOOTHILL RANCH, Calif., Aug. 18, 2020 /PRNewswire/ -- BIOLASE, Inc.
BIOLASE, Inc. (BIOL) CEO Todd Norbe on Q2 2020 Results - Earnings Call Transcript
FOOTHILL RANCH, Calif., Aug. 13, 2020 /PRNewswire/ -- BIOLASE, Inc.
FOOTHILL RANCH, Calif., Aug. 6, 2020 /PRNewswire/ -- BIOLASE, Inc.
IRVINE, Calif., July 22, 2020 /PRNewswire/ -- BIOLASE, Inc.
IRVINE, Calif., July 16, 2020 /PRNewswire/ -- BIOLASE, Inc.
IRVINE, Calif., July 13, 2020 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced data published in the Journal of Periodontology from a clinical ...
IRVINE, Calif., July 9, 2020 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, announced today that BIOLASE CEO Todd Norbe has been invited to participate in a ...
IRVINE, Calif., July 2, 2020 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), a global leader in dental lasers, today announced that the subscription period for the rights offering has commenced....
IRVINE, Calif., June 22, 2020 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), a global leader in dental lasers, today provided an informational update to stockholders regarding its proposed righ...
IRVINE, Calif., June 11, 2020 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced the closing on June 10, 2020 of its previously announced registe...
IRVINE, Calif., June 8, 2020 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced that it has entered into a securities purchase agreement with ins...
BIOLASE Inc (BIOL) CEO Todd Norbe on Q1 2020 Results - Earnings Call Transcript
BIOLASE, Inc. (BIOL) CEO Todd Norbe on Q4 2019 Results - Earnings Call Transcript
BIOLASE, Inc. (BIOL) CEO Todd Norbe on Q3 2019 Results - Earnings Call Transcript
BIOLASE, Inc. (BIOL) CEO Todd Norbe on Q2 2019 - Earnings Call Transcript
Lower investment in MedTech might prove to be a concern, more so as gains within this space are staggering.
Biolase's (BIOL) CEO Todd Norbe on Q1 2019 Results - Earnings Call Transcript
About BIOL
BIOLASE, together with its subsidiaries, develops, manufactures, markets, and sells laser systems for dental practitioners and their patients in the United States and internationally. Its dental laser systems allow dentists, periodontists, endodontists, oral surgeons, and other dental specialists to perform a range of minimally invasive dental procedures, such as cosmetic, restorative, and complex surgical applications. The company offers Waterlase all-tissue dental laser systems for cutting soft and hard tissues; diode laser systems to perform... [Read more...]
| Industry Medical Devices | IPO Date Nov 13, 1992 |
| CEO Todd Norbe | Employees 157 |
| Stock Exchange NASDAQ | Ticker Symbol BIOL |
Financial Performance
In 2019, BIOLASE, Inc.'s revenue was $37.80 million, a decrease of -18.10% compared to the previous year's $46.16 million. Losses were -$17.86 million, -17.02% less than in 2018.
Analyst Forecasts
According to 4 analysts, the average rating for BIOLASE, Inc. stock is "Buy." The 12-month stock price forecast is 1.41, which is an increase of 35.58% from the latest price.